Jan 5, 2022 · ABELCET ® is indicated for the treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy. This is based on open-label treatment of patients judged by their physicians to be intolerant to or failing conventional amphotericin B therapy (See Description Of Clinical Studies).

ABELCET® is indicated for the treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy. This is based on open-label treatment of patients

Feb 17, 2025 · Abelcet is an antifungal medicine that is used to treat serious, life-threatening fungal infections that cannot be treated with other antifungal medications. Abelcet may also be used for purposes not listed in this medication guide.

Nov 23, 2023 · Abelcet package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Abelcet (Amphotericin B lipid complex injection) is used to treat serious, possibly life-threatening fungal infections.

Jan 18, 2025 · Amphotericin B is commonly used to treat certain fungal infections as well as a type of parasite infection known as leishmaniasis. Amphotericin B may not be appropriate for some fungal...

COMMON BRAND NAME(S): Abelcet, Ambisome, Amphotec. USES: This medication is used to treat a variety of serious fungal infections. It is often used in patients who cannot tolerate or who do not...

Nov 21, 2023 · ABELCET ® is a sterile, pyrogen-free suspension for intravenous infusion. ABELCET ® consists of amphotericin B complexed with two phospholipids in a 1:1 drug-to-lipid molar ratio. The two phospholipids, l-α-dimyristoylphosphatidylcholine (DMPC) and l-α-dimyristoylphosphatidylglycerol (DMPG), are present in a 7:3 molar ratio.

Feb 16, 2020 · Learn about Abelcet: What is it used for, what you need to know before taking, important warnings and safety info, how to take, side effects and more...

ABELCET ® is a sterile, pyrogen-free suspension for intravenous infusion. ABELCET ® consists of amphotericin B complexed with two phospholipids in a 1:1 drug-to-lipid molar ratio. The two phospholipids, l-α-dimyristoylphosphatidylcholine (DMPC) and l-α-dimyristoylphosphatidylglycerol (DMPG), are present in a 7:3 molar ratio.